Medlab Clinical: Edison Open House Healthcare 2022

Medlab Clinical: Edison Open House Healthcare 2022

Medlab Clinical — 2 videos in collection

Medlab Clinical is an Australian biotechnology company that is developing therapeutics using its proprietary delivery platform NanoCelle. Its most advanced programme is in cancer pain management with lead drug candidate NanaBis, a medicinal cannabis product for cancer-related bone pain.

• Please tell us more about the recent change in focus from a nutraceutical to a biotech business.
• What is NanoCelle and what does it do?
• Are there any potential issues with the NanoCelle technology?
• What kind of compounds are you focusing on at present and what would you say is your leading contender?
• Do you think your Australian compassionate programme might be replicated in other countries?
• What are the timelines for the clinical development of NanaBis?
• Have you seen any impact on your workflow from COVID-19?
• Following the recent addition of the US patent for NanoCelle, what is your current patent portfolio?


You may also be interested in these:

Healthcare

Medlab Clinical – executive interview

Cookie Policy Overview
Edison Group

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping us understand which section of the website you find more interesting and useful. See our Cookie Policy for more information.

Strictly necessary and functional

These cookies are used to deliver our website and content. Strictly necessary cookies relate to our hosting environment, and functional cookies are used to facilitate social logins, social sharing and rich-media content embeds.

Advertising

Advertising Cookies collect information about your browsing habits such as the pages you visit and links you follow. These audience insights are used to make our website more relevant.

Performance

Performance Cookies collect anonymous information designed to help us improve the site and respond to the needs of our audiences. We use this information to make our site faster, more relevant and improve the navigation for all users.